LEADER 04711nam  2200649Ia 450 
001 9910456053203321
005 20200520144314.0
010   $a1-280-24677-4
010   $a9786610246779
010   $a0-309-58152-4
010   $a0-585-14491-5
035   $a(CKB)110986584750692
035   $a(EBL)3376089
035   $a(SSID)ssj0000266426
035   $a(PQKBManifestationID)11206711
035   $a(PQKBTitleCode)TC0000266426
035   $a(PQKBWorkID)10301177
035   $a(PQKB)11591059
035   $a(MiAaPQ)EBC3376089
035   $a(Au-PeEL)EBL3376089
035   $a(CaPaEBR)ebr10055083
035   $a(CaONFJC)MIL24677
035   $a(OCoLC)923261025
035   $a(EXLCZ)99110986584750692
100   $a19851205d1985      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aVaccine supply and innovation$b[electronic resource] /$fDivision of Health Promotion and Disease Prevention, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1985
215   $a1 online resource (210 p.)
225 1 $aPublication IOM ;$vno. 85-02
300   $aDescription based upon print version of record.
311   $a0-309-03544-9 
320   $aIncludes bibliographical references.
327   $a""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""
327   $a""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities""
327   $a""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS""
327   $a""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY""
327   $a""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions""
327   $a""Public-Private Sector Interactions""
410  0$aIOM publication ;$v85-02.
606   $aVaccines$xResearch
606   $aImmunization
608   $aElectronic books.
615  0$aVaccines$xResearch.
615  0$aImmunization.
676   $a338.47615372
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456053203321
996   $aVaccine supply and innovation$92177201
997   $aUNINA